We are pleased to announce that ACTS has joined St. Peter’s Health Partners Medical Associates.
SPHPMA is one of the Capital Region’s largest multi-specialty physician groups with more than 850 physicians and advanced practitioners in more than 100 locations.
To learn more about SPHPMA, click here.
ABOUT US
Albany Cardiothoracic Surgeons is the oldest heart surgery practice dedicated to cardiothoracic surgery in the Capital District. Our history is a 50-year long tradition of working as a coordinated team to provide expert, high quality, compassionate cardiothoracic surgical care. We serve residents in a broad tri-state area, centered in the Capital District of New York.
Albany Cardiothoracic Surgeons is the exclusive provider of cardiac surgery at St. Peters Hospital in Albany, New York. Our services range from the latest techniques of minimally invasive surgery to the most complex and difficult surgery requiring combinations of traditional and advanced techniques. Our surgical results have surpassed both the state and national standards.
Please see our contact information for office locations and directions.
OUR MISSION
- We treat all persons with dignity, hospitality and compassion, calling forth their best human potential.
- We provide comprehensive services that support healthy communities, including quality medical care with holistic approaches to healing body, mind and spirit.
- We care for and strengthen the ministry and all resources entrusted to us.
- We advocate for accessible health care and quality of life for all, especially those who are poor.
- We respond with courage and integrity to needs for services in a rapidly changing health care environment.
LATEST CARDIOLOGY NEWS
(MedPage Today) -- DENVER -- Supplementation with high-dose cholecalciferol (vitamin D3) did not improve overall survival in patients receiving dialysis for end-stage kidney disease, according to findings from the SIMPLIFIED trial.
Overall survival...
(MedPage Today) -- DENVER -- Daily low-dose aspirin did not significantly reduce major vascular events in adults with chronic kidney disease (CKD), the randomized ATTACK trial showed.
Over a mean follow-up of 3.1 years, 2.4% of adults with CKD...
(MedPage Today) -- We are currently in a "golden age of medical science," yet in a "dark age of healthcare delivery." An important illustration is the diagnosis and treatment of America's number one cause of death and disability, coronary artery...
(MedPage Today) -- DENVER -- Treatment with SGLT2 inhibitors was linked with modest but statistically significant increases in hemoglobin and hematocrit levels across a broad spectrum of patient populations, according to a systematic review and...
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El Paso, look at the top medical...